Emerald Mutual Fund Advisers Trust Vanda Pharmaceuticals Inc. Transaction History

Emerald Mutual Fund Advisers Trust

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 Apr 30, 2020	SELL	$7.5 - $16.8 $1.89 Million - $4.23 Million	-251,730 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$12.38 - $17.47 $3.12 Million - $4.4 Million	251,730 New	251,730 $4.13 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.